Viridian Therapeutics, INC.\De (VRDN) — SC 13D/A Filings

All SC 13D/A filings from Viridian Therapeutics, INC.\De. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (3)

Fairmount Funds Management Ups Stake in Viridian Therapeutics — Sep 17, 2024 Risk: medium
Fairmount Funds Management LLC, through Fairmount Healthcare Fund II GP LLC, has amended its Schedule 13D filing regarding Viridian Therapeutics, Inc. As of Sep
Fairmount Funds Boost Viridian Therapeutics Stake to 15.1% — Apr 1, 2024 Risk: medium
Fairmount Funds Management LLC, along with its group members Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, has amended its Schedule
Fairmount Funds Amends Viridian Therapeutics Stake (SC 13D/A) — Jan 24, 2024
Fairmount Funds Management LLC, along with Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, filed an amended Schedule 13D on January 22

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX